Senate Special Committee on Aging

opening door to brick wall
Biotech

Senate hearing takes aim at FDA's rare disease review process

“The members of the panel were like talking to a brick wall,” Jeremy Schmahmann, M.D., testified about his experience at three FDA panels.
Gabrielle Masson Feb 26, 2026 3:50pm